Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Tipo de estudo
Intervalo de ano
1.
Pakistan Journal of Medical Sciences. 2007; 23 (2): 259-263
em Inglês | IMEMR | ID: emr-84796

RESUMO

The clinico-pathologic features, incidence and pattern of presentation of patients with the rare hairy cell leukaemia in University of Benin City Teaching Hospital, a major tertiary health centre in Niger Delta region of Nigeria have not been previously documented. All cases that presented from 1993 to 2003 were reviewed and this rare leukaemia constituted 1.5% of all haematological malignancies. Median age at presentation was 40 years. Typical clinical signs of pancytopenia and massive splenomegaly were found. Lymphadenopathy was rare. Normalization of pancytopenia was achieved by splenectomy followed by cytostatic agents but increased susceptibility to infection was not reduced. Four patients received interferon-alpha two patients, cladribine with prednisolone following splenectomy


Assuntos
Humanos , Masculino , Feminino , Leucemia de Células Pilosas/diagnóstico , Leucemia de Células Pilosas/terapia , Hospitais
2.
Pakistan Journal of Medical Sciences. 2005; 21 (3): 253-257
em Inglês | IMEMR | ID: emr-176424

RESUMO

To determine the incidence and survival of patients with Leukaemia in the Niger Delta region of Nigeria, noted for its petrochemical industries. A prospective study of 120 cases of leukaemia from December 1993 to 2003. University of Benin Teaching Hospital, Nigeria. Demographic and clinical information including duration of illness before presentation was obtained by oral interview. Chronic Myeloid Leukaemia [CML] was the most frequent subtype [33.3%]. There was a strong association between the white blood cell count at presentation and 1 year survival in CML and CLL patients [p= 0.0001]. The 2-year survival for CML, CLL and PLL was 12.5%, 40% and 32% respectively. Duration of illness before presentation was found to influence 1-year survival in CML [p=0.0075] and CLL [p= 0.0001]. The 2-year survival is still very poor and this may not be unconnected with late presentation and other strong limiting factors

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA